SRT-278

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSRT-278
Drug Alias NamerCGG repeats targeting compound (Scripps Research Institute)SRT-278
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFragile X Messenger Ribonucleoprotein 1 modulators
TargetsFragile X Messenger Ribonucleoprotein 1
Therapy Area/IndicationsFragile X Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Scripps Research Institute Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSMaRT Therapeutics IncThe Scripps Research Institute Inc
Active IndicationsN/A
Inactive IndicationsFragile X Syndrome

Other Information

ATC CodeN/A
Related LinksN/A